Pharmacokinetic aspects of caffeine in premature infants

Mp De Carolis, Costantino Romagnoli, U Muzii, Giuseppe Gio Batta Tortorolo, Marcello Chiarotti, Nadia De Giovanni, A. Carnevale

Research output: Contribution to journalArticle

Abstract

The pharmacokinetic profile of caffeine was studied in 15 premature infants. Five infants received a single intravenous dose of 10 mg/kg of caffeine citrate 100% at birth and on the 15th day of life. Ten neonates were studied during daily therapy with caffeine for prophylaxis of idiopathic apnea. The time course of plasma and urinary concentrations of caffeine and theophylline shows that caffeine is transformed to theophylline at birth, while total urinary xanthines decrease significantly (p less than 0.001) 72 h after the loading dose given on the 15th day of life. During the whole period of treatment, the decrease in total urinary xanthines and the constant urinary percentage elimination of theophylline are due to further metabolism of theophylline. We confirm that the intravenous loading dose of 10 mg/kg can rapidly obtain therapeutic blood levels of caffeine. We also confirm that the maintenance therapy can be carried out with a single daily dose.
Original languageEnglish
Pages (from-to)117-122
Number of pages6
JournalDevelopmental Pharmacology and Therapeutics
Volume16
Publication statusPublished - 1991
Externally publishedYes

Keywords

  • Biotransformation
  • Caffeine
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Injections, Intravenous
  • Sleep Apnea Syndromes
  • Theophylline
  • Xanthines

Fingerprint

Dive into the research topics of 'Pharmacokinetic aspects of caffeine in premature infants'. Together they form a unique fingerprint.

Cite this